Hedge Fund - Samlyn Capital
Biogen Inc. (BIIB)
Holding History Records
| No. | Filing Period | Value | % of Portfolio | Number of Shares | Avg. Quarterly Share Price |
|---|---|---|---|---|---|
| 1 | 2023 - Q4 (2023-12-31) | $0 | 0% | 0 | $245.62 |
| 2 | 2023 - Q3 (2023-09-30) | $108,035,438 | 1.76% | 420,355 | $267.47 |
| 3 | 2023 - Q2 (2023-06-30) | $112,593,229 | 1.9% | 395,272 | $297.84 |
| 4 | 2023 - Q1 (2023-03-31) | $110,958,993 | 2.01% | 399,090 | $276.70 |
| 5 | 2022 - Q4 (2022-12-31) | $73,927,394 | 1.44% | 266,963 | $282.44 |
| 6 | 2022 - Q3 (2022-09-30) | $36,421,000 | 0.67% | 136,405 | $212.38 |
| 7 | 2022 - Q2 (2022-06-30) | $29,079,000 | 0.58% | 142,586 | $204.43 |
| 8 | 2022 - Q1 (2022-03-31) | $37,701,000 | 0.54% | 179,012 | $217.46 |
| 9 | 2021 - Q4 (2021-12-31) | $43,065,000 | 0.59% | 179,495 | $257.12 |
| 10 | 2021 - Q3 (2021-09-30) | $34,620,000 | 0.46% | 122,335 | $327.75 |
| 11 | 2021 - Q2 (2021-06-30) | $130,277,000 | 1.91% | 376,231 | $302.94 |
| 12 | 2020 - Q4 (2020-12-31) | $0 | 0% | 0 | $259.08 |
| 13 | 2020 - Q3 (2020-09-30) | $30,531,000 | 0.54% | 107,626 | $278.91 |
| 14 | 2020 - Q2 (2020-06-30) | $31,915,000 | 0.59% | 119,287 | $300.59 |
| 15 | 2020 - Q1 (2020-03-31) | $32,539,000 | 0.82% | 102,847 | $303.47 |
| 16 | 2019 - Q4 (2019-12-31) | $34,741,000 | 0.72% | 117,078 | $277.46 |
| 17 | 2019 - Q1 (2019-03-31) | $0 | 0% | 0 | $314.89 |
| 18 | 2018 - Q4 (2018-12-31) | $38,712,000 | 0.92% | 128,645 | $319.14 |
| 19 | 2018 - Q3 (2018-09-30) | $65,097,000 | 1.47% | 184,251 | $344.30 |
| 20 | 2018 - Q2 (2018-06-30) | $23,391,000 | 0.54% | 80,592 | $281.15 |
| 21 | 2018 - Q1 (2018-03-31) | $21,843,000 | 0.47% | 79,772 | $310.41 |
| 22 | 2017 - Q4 (2017-12-31) | $106,438,000 | 2.46% | 334,114 | $320.80 |
| 23 | 2017 - Q3 (2017-09-30) | $144,236,000 | 3.66% | 460,643 | $296.11 |
| 24 | 2017 - Q2 (2017-06-30) | $192,801,000 | 4.7% | 710,500 | $264.42 |
| 25 | 2017 - Q1 (2017-03-31) | $118,144,000 | 2.74% | 432,100 | $282.75 |
| 26 | 2016 - Q4 (2016-12-31) | $44,409,000 | 1% | 156,600 | $296.43 |
| 27 | 2016 - Q3 (2016-09-30) | $119,422,000 | 2.85% | 381,502 | $296.18 |
| 28 | 2016 - Q2 (2016-06-30) | $128,388,000 | 3.06% | 530,927 | $263.54 |
| 29 | 2016 - Q1 (2016-03-31) | $77,447,000 | 1.66% | 297,507 | $264.15 |
| 30 | 2015 - Q4 (2015-12-31) | $74,137,000 | 1.53% | 242,000 | $287.35 |
| 31 | 2015 - Q3 (2015-09-30) | $53,576,000 | 0.98% | 183,600 | $330.23 |
| 32 | 2013 - Q4 (2013-12-31) | $0 | 0% | 0 | $258.65 |
| 33 | 2013 - Q3 (2013-09-30) | $21,571,000 | 0.6% | 89,596 | $223.81 |
| 34 | 2013 - Q2 (2013-06-30) | $18,615,000 | 0.53% | 86,500 | $213.68 |
| 35 | 2012 - Q4 (2012-12-31) | $0 | 0% | 0 | $147.07 |
| 36 | 2012 - Q3 (2012-09-30) | $17,457,000 | 0.75% | 117,000 | $147.13 |
| 37 | 2012 - Q1 (2012-03-31) | $32,634,000 | 1.08% | 259,000 | $118.81 |
| 38 | 2011 - Q4 (2011-12-31) | $32,717,000 | 1.04% | 297,300 | $109.04 |
| 39 | 2011 - Q3 (2011-09-30) | $9,129,000 | 0.35% | 98,000 | $97.12 |
The displayed share prices are average quarterly stock market prices.